Phalanx Anastrozole / Arimidex 1mg

Description

Phalanx Anastrozole is pharmaceutical-grade aromatase inhibition — 1mg per tablet of the compound that has set the standard for oestrogen control in performance pharmacology for over two decades. Anastrozole competitively inhibits the aromatase enzyme (CYP19A1), blocking the conversion of androgens (testosterone, androstenedione) into oestrogens at the source. At 1mg, this is the reference dose — providing approximately 97% aromatase inhibition in clinical studies, capable of reducing serum oestradiol by over 80% in most users. For cycle management, Anastrozole is typically deployed at 0.25–1mg every other day to every day depending on aromatase burden, cycle composition, and individual sensitivity. Precision dosing is critical — over-suppression of oestradiol is as problematic as elevation, causing joint pain, mood collapse, libido loss, and cardiovascular risk. Each Phalanx Anastrozole tablet is independently verified at 99%+ purity by Puralytix, giving you the confidence to dial your oestrogen with accuracy. Oestradiol should be monitored via blood test to guide Anastrozole dosing — target oestradiol of 20–30 pg/mL during performance cycles maintains the hormonal balance needed for sexual function, mood, libido, cardiovascular health, and joint lubrication. Over-suppression below 15 pg/mL produces its own distinct symptom profile. Dose carefully. Bloodwork guides more precisely than any fixed protocol.